UnknownNCT00900211
Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX
Studying Angiosarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- The Christie NHS Foundation Trust
- Principal Investigator
- Catherine WestThe Christie NHS Foundation Trust
- Intervention
- microarray analysis(genetic)
- Enrollment
- 400 enrolled
- Eligibility
- 16 years · All sexes
- Timeline
- 2007
Study locations (12)
- Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust, Birmingham, England, United Kingdom
- Royal Orthopedic Hospital NHS Trust, Birmingham, England, United Kingdom
- Bristol Haematology and Oncology Centre, Bristol, England, United Kingdom
- Gloucestershire Oncology Centre at Cheltenham General Hospital, Cheltenham, England, United Kingdom
- Royal National Orthopaedic Hospital NHS Trust, Cheltenham, England, United Kingdom
- Middlesex Hospital, London, England, United Kingdom
- Christie Hospital, Manchester, England, United Kingdom
- Nottingham City Hospital, Nottingham, England, United Kingdom
- Cancer Research Centre at Weston Park Hospital, Sheffield, England, United Kingdom
- Robert Jones and Agnes Hunt Orthopaedic and District Hospital NHS Trust, Shropshire, England, United Kingdom
- Beatson West of Scotland Cancer Centre, Glasgow, Scotland, United Kingdom
- Glan Clwyd Hospital, Rhyl, Denbighshire, Wales, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00900211 on ClinicalTrials.govOther trials for Angiosarcoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06898970Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for AngiosarcomaVarun Monga, MBBS
- RECRUITINGPHASE2NCT07007273Pembrolizumab for Advanced Cutaneous Sarcomas Not Including AngiosarcomaH. Lee Moffitt Cancer Center and Research Institute
- RECRUITINGNCT06715579Cardiac Angiosarcoma International RegistryImmune Oncology Research Institute
- RECRUITINGPHASE2NCT06849986IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS)Fudan University
- RECRUITINGPHASE2NCT06673628Pembrolizumab Plus Lenvatinib in Unresectable Cutaneous Angiosarcoma PatientsNational Cancer Center, Japan
- RECRUITINGPHASE1NCT06440005A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid TumorsAngiex, Inc.
- RECRUITINGNCT06375941Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStarsItalian Sarcoma Group
- RECRUITINGNCT06541652A French Multicenter Observational Retrospective Study of Rare Primary Liver CancersFederation Francophone de Cancerologie Digestive